Oral Binding Agents in the Management of Hyperkalemia in the Emergency Department and Critical Care Setting

This EMCREG-International On the Go program serves as a state of the art evaluation of oral binding agents in the management of hyperkalemia in the emergency department and critical care Setting. Clinicians participating in this program and caring for patients suffering from hyperkalemia will be better prepared to understand the role of the various oral binding agents. Dr. Frank Peacock will not only describe the oral potassium cation exchange agents commercially available, but review the phase 3 trial using sodium zirconium cyclosilicate, discussing its mechanism of action versus other oral cation exchange agents for hyperkalemia.